Researchers find infiltrating lymphocytes tie to survival in patients with recurrent larynx cancer; findings suggest super-boosting the immune system before additional treatment.
Rosemary (Rosie) Clandos is a contributing health and science writer. She has written for the Los Angeles Times, Kaiser Permanente, U.S. Department of Defense, National Science Foundation, and several universities and medical centers on the West Coast. Rosie has covered topics ranging from medicine to microelectromechanical systems. As the author of “Health Hunt on the Internet: Find and Use Reliable Medical Information,” she specializes in compelling storytelling.
Even without symptoms of concussion, researchers studying high school football players found two elevated biomarkers that are associated with brain injury.
Therapist- and computer-led alcohol interventions held in the emergency department also can reduce teenage dating violence perpetration and depression symptoms, a new study finds.
Providing physicians with virtual access to specialists can be lifesaving to liver disease patients. A new study finds that it boosts survival rates by 54 percent.
Successfully tested in mice, targeted drug and gene therapies might one day benefit patients with a deadly lung disease, new U-M research finds.
Immunotherapy cancer drugs can cause a potentially vision-robbing side effect. In a new report, Michigan Medicine experts discuss the risks and what oncologists should know.